Literature DB >> 29399183

MicroRNA-509-3p inhibits cell proliferation and invasion via downregulation of X-linked inhibitor of apoptosis in glioma.

Peng Du1, Xinping Luan1, Yiwei Liao2, Yiti Mu1, Yang Yuan1, Jingxuan Xu1, Jingjing Zhang1.   

Abstract

Malignant glioma is an aggressive type of cancer. Increasing evidence has suggested that microRNAs (miRs) regulate gene expression post-transcriptionally to affect cancer development and progression. Aberrant expression of miR-509-3p has been reported in cancer studies. However, the expression and mechanism of its function in glioma remains unclear. The present study demonstrated that miR-509-3p was downregulated in glioma tissue samples relative to non-tumor tissues, and that low miR-509-3p expression was associated with a reduced overall survival time. Functional studies revealed that the overexpression of miR-509-3p inhibited cell proliferation, induced apoptosis and suppressed cell migration and invasion via negatively regulating the expression of X-linked inhibitor of apoptosis. The data therefore suggested that miR-509-3p serves an important role in the development and progression of glioma, implicating its possible application in clinical practice as a biomarker and a potential novel therapeutic target.

Entities:  

Keywords:  X-linked inhibitor of apoptosis; glioma; microRNA-509-3p

Year:  2017        PMID: 29399183      PMCID: PMC5772864          DOI: 10.3892/ol.2017.7390

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Malignant gliomas in adults.

Authors:  Patrick Y Wen; Santosh Kesari
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

3.  MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.

Authors:  Mick D Edmonds; Kelli L Boyd; Tamara Moyo; Ramkrishna Mitra; Robert Duszynski; Maria Pia Arrate; Xi Chen; Zhongming Zhao; Timothy S Blackwell; Thomas Andl; Christine M Eischen
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

4.  MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.

Authors:  Zhengming Su; Duqun Chen; Enpu Zhang; Yifan Li; Zuhu Yu; Min Shi; Zhimao Jiang; Liangchao Ni; Shangqi Yang; Yaoting Gui; Jiongxian Ye; Yongqing Lai
Journal:  Mol Med Rep       Date:  2015-03-17       Impact factor: 2.952

5.  Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.

Authors:  Brett E Johnson; Tali Mazor; Chibo Hong; Michael Barnes; Koki Aihara; Cory Y McLean; Shaun D Fouse; Shogo Yamamoto; Hiroki Ueda; Kenji Tatsuno; Saurabh Asthana; Llewellyn E Jalbert; Sarah J Nelson; Andrew W Bollen; W Clay Gustafson; Elise Charron; William A Weiss; Ivan V Smirnov; Jun S Song; Adam B Olshen; Soonmee Cha; Yongjun Zhao; Richard A Moore; Andrew J Mungall; Steven J M Jones; Martin Hirst; Marco A Marra; Nobuhito Saito; Hiroyuki Aburatani; Akitake Mukasa; Mitchel S Berger; Susan M Chang; Barry S Taylor; Joseph F Costello
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

6.  miR-126 Drives Quiescence and Self-Renewal in Leukemic Stem Cells.

Authors:  Simon Raffel; Andreas Trumpp
Journal:  Cancer Cell       Date:  2016-02-08       Impact factor: 31.743

7.  XIAP expression is associated with pancreatic carcinoma outcome.

Authors:  Shengmian Li; Jianjian Sun; Jian Yang; Lan Zhang; LE Wang; Xiaoling Wang; Zhanjun Guo
Journal:  Mol Clin Oncol       Date:  2013-01-02

8.  miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α.

Authors:  F Xing; S Sharma; Y Liu; Y-Y Mo; K Wu; Y-Y Zhang; R Pochampally; L A Martinez; H-W Lo; K Watabe
Journal:  Oncogene       Date:  2015-02-09       Impact factor: 9.867

9.  Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression.

Authors:  Amy V Paschall; Mary A Zimmerman; Christina M Torres; Dafeng Yang; May R Chen; Xia Li; Erhard Bieberich; Aiping Bai; Jacek Bielawski; Alicja Bielawska; Kebin Liu
Journal:  BMC Cancer       Date:  2014-01-15       Impact factor: 4.430

10.  MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.

Authors:  Zhanyao Tan; Haiqing Zheng; Xiangxia Liu; Wenhui Zhang; Jinrong Zhu; Geyan Wu; Lixue Cao; Junwei Song; Shu Wu; Libing Song; Jun Li
Journal:  Oncotarget       Date:  2016-04-26
View more
  5 in total

1.  miR-509 inhibits cancer stemness properties in oral carcinomas via directly targeting PlK1.

Authors:  Ming-Yi Lu; Chih-Yuan Fang; Pei-Ling Hsieh; Yi-Wen Liao; Lo-Lin Tsai; Cheng-Chia Yu
Journal:  J Dent Sci       Date:  2021-10-08       Impact factor: 3.719

2.  MicroRNA-466 inhibits osteosarcoma cell proliferation and induces apoptosis by targeting CCND1.

Authors:  Wei Cao; Le Fang; Siyong Teng; Hongwei Chen; Tiejun Liu
Journal:  Exp Ther Med       Date:  2018-10-22       Impact factor: 2.447

3.  MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer.

Authors:  Deepak Narayanan Iyer; Dominic Chi-Chung Foo; Oswens Siu-Hung Lo; Timothy Ming-Hun Wan; Xue Li; Ryan Wai-Yan Sin; Roberta Wen-Chi Pang; Wai-Lun Law; Lui Ng
Journal:  BMC Cancer       Date:  2022-03-31       Impact factor: 4.430

4.  Knockdown of LINC00467 contributed to Axitinib sensitivity in hepatocellular carcinoma through miR-509-3p/PDGFRA axis.

Authors:  Wei Li; Yufeng He; Wei Chen; Wenling Man; Qiang Fu; Hongtong Tan; Huanqing Guo; Jingnan Zhou; Po Yang
Journal:  Gene Ther       Date:  2020-03-27       Impact factor: 5.250

5.  MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Huiming Zhang; Shuang Liu; Liqiang Chen; Yanliang Sheng; Wenzhe Luo; Gang Zhao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.